当前位置: 首页 > 详情页

Efficacy of Drug-Eluting Balloons for Patients With In-Stent Restenosis: A Meta-Analysis of 8 Randomized Controlled Trials

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Epidemiol, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [2]Capital Med Univ, Friendship Hosp, Dept Hematol, Beijing, Peoples R China; [3]Baton Rouge Gen Med Ctr, Dept Internal Med, Baton Rouge, LA USA; [4]Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA; [5]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing 100021, Peoples R China
出处:
ISSN:

关键词: coronary artery disease in-stent restenosis drug-eluting balloon drug-eluting stent balloon angioplasty

摘要:
The optimal treatment for in-stent restenosis (ISR) of both bare-metal stent (BMS) and drug-eluting stent (DES) is currently unclear. The aim of this meta-analysis was to assess the role of drug-eluting balloon (DEB) as an optional treatment for ISR. We searched PubMed, MEDLINE, EMBASE, BIOS, and Web of Science from 2005 to July 2014. Eight studies, enrolling 1413 patients were included. Main end points were late lumen loss (LLL), binary in-segment restenosis (BR), major adverse cardiac events (MACEs), target lesion revascularization (TLR), death, myocardial infarction (MI), and stent thrombosis (ST). When compared to plain old balloon angioplasty (POBA), DEB treatment significantly reduced the risk of MACE (risk rato [RR] 0.37, P < .01), death (RR 0.44, P = .04), TLR (RR 0.27, P < .01), BR (RR [95% CI]: 0.23[0.12 to 0.43], P < .01) and associated with better outcomes of LLL ( 0.50 [ 0.65 to 0.35] mm, P < .01). However, the differences were not significant between DEB treatment and DES treatment in all primary and secondary end points. The DEB was a better option to treat ISR when compared to POBA. However, it had similar effects as DES.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 3 区 医学
小类 | 4 区 外周血管病
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 外周血管病
JCR分区:
出版当年[2014]版:
Q2 PERIPHERAL VASCULAR DISEASE
最新[2023]版:
Q2 PERIPHERAL VASCULAR DISEASE

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Epidemiol, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China;
通讯作者:
通讯机构: [5]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing 100021, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16938 今日访问量:0 总访问量:903 更新日期:2025-03-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院